Second Reply to: "Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?"
Ann Surg Oncol
.
2021 Dec;28(Suppl 3):811-812.
doi: 10.1245/s10434-021-09851-w.
Epub 2021 Mar 18.
Author
Giovanni Corso
1
2
Affiliations
1
Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy. giovanni.corso@ieo.it.
2
Department of Oncology and Hemato-Oncology, Faculty of Medicine, University of Milan, Milan, Italy. giovanni.corso@ieo.it.
PMID:
33738718
DOI:
10.1245/s10434-021-09851-w
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / drug therapy
Carcinoma, Ductal, Breast*
Female
Humans
Triple Negative Breast Neoplasms* / drug therapy